PubMed

Glucagon, in concert with insulin, supports the postabsorptive plasma glucose concentration in humans.

Breckenridge SM, Cooperberg BA, Arbelaez AM, Patterson BW, Cryer PE.

Diabetes. 2007 Oct;56(10):2442-8. Epub 2007 Jul 2.PMID: 17606872 [PubMed - indexed for MEDLINE]Related articlesFree article

Basal insulin, glucagon, and growth hormone replacement.

Breckenridge SM, Raju B, Arbelaez AM, Patterson BW, Cooperberg BA, Cryer PE.

Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1303-10. Epub 2007 Aug 21.PMID: 17711984 [PubMed - indexed for MEDLINE]Related articlesFree article

Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.

Banarer S, McGregor VP, Cryer PE.

Diabetes. 2002 Apr;51(4):958-65.PMID: 11916913 [PubMed - indexed for MEDLINE]Related articlesFree article

Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations.

Krentz AJ, Boyle PJ, Macdonald LM, Schade DS.

Metabolism. 1994 Jan;43(1):24-31.PMID: 8289671 [PubMed - indexed for MEDLINE]Related articles

Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.

Nielsen MF, Wise S, Dinneen SF, Schwenk WF, Basu A, Rizza RA.

Diabetes. 1997 Dec;46(12):2007-16.PMID: 9392488 [PubMed - indexed for MEDLINE]Related articles

Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man.

Rosen SG, Clutter WE, Berk MA, Shah SD, Cryer PE.

J Clin Invest. 1984 Feb;73(2):405-11.PMID: 6142057 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.

Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, Meyer C.

Diabetes Care. 2005 May;28(5):1124-31.PMID: 15855577 [PubMed - indexed for MEDLINE]Related articlesFree article

Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.

Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA.

Diabetes. 1998 Nov;47(11):1735-47.PMID: 9792543 [PubMed - indexed for MEDLINE]Related articlesFree article

Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.

Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA.

Diabetologia. 2002 Oct;45(10):1410-5. Epub 2002 Sep 5. Erratum in: Diabetologia. 2003 Nov;46(11):1589. PMID: 12378382 [PubMed - indexed for MEDLINE]Related articles

Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.

Caprio S, Tamborlane WV, Zych K, Gerow K, Sherwin RS.

Diabetes. 1993 Apr;42(4):550-5.PMID: 8454105 [PubMed - indexed for MEDLINE]Related articles

Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans.

Petersen KF, Sullivan JT.

Diabetologia. 2001 Nov;44(11):2018-24.PMID: 11719833 [PubMed - indexed for MEDLINE]Related articles

Restoration of stable metabolic conditions during islet suppression in dogs.

Bradley DC, Bergman RN.

Am J Physiol. 1992 Apr;262(4 Pt 1):E532-8.PMID: 1348903 [PubMed - indexed for MEDLINE]Related articles

Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.

Basu R, Basu A, Nielsen M, Shah P, Rizza RA.

J Clin Endocrinol Metab. 1999 Jul;84(7):2314-9.PMID: 10404795 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of amino acids on glucose disposal.

Boden G, Tappy L.

Diabetes. 1990 Sep;39(9):1079-84.PMID: 1974539 [PubMed - indexed for MEDLINE]Related articles

Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA.

J Clin Endocrinol Metab. 2000 Nov;85(11):4053-9.PMID: 11095432 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function.

Di Mauro M, Papalia G, Le Moli R, Nativo B, Nicoletti F, Lunetta M.

Diabetes Res Clin Pract. 2001 Jan;51(1):45-50.PMID: 11137181 [PubMed - indexed for MEDLINE]Related articles

Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.

Paolisso G, Scheen AJ, Luyckx AS, Lefebvre PJ.

Am J Physiol. 1987 Jan;252(1 Pt 1):E1-7.PMID: 3544860 [PubMed - indexed for MEDLINE]Related articles

Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man.

Ward WK, Best JD, Halter JB, Porte D Jr.

J Clin Endocrinol Metab. 1984 Mar;58(3):449-53.PMID: 6141177 [PubMed - indexed for MEDLINE]Related articles

Fructose amplifies counterregulatory responses to hypoglycemia in humans.

Gabriely I, Hawkins M, Vilcu C, Rossetti L, Shamoon H.

Diabetes. 2002 Apr;51(4):893-900.PMID: 11916904 [PubMed - indexed for MEDLINE]Related articlesFree article

Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.

Paolisso G, Sgambato S, Passariello N, Scheen A, D'Onofrio F, Lefèbvre PJ.

Diabetes. 1987 May;36(5):566-70.PMID: 2883055 [PubMed - indexed for MEDLINE]Related articles